Dr. Parvin Peddi is the Director of Breast Medical Oncology at Margie Petersen Breast Cancer Center. After nearly a decade at UCLA where she was a member of the Medical Oncology faculty and lead Medical Oncology at the Revlon UCLA Breast Cancer Clinic at Ronald Reagan UCLA Medical Center, Dr. Peddi joined the Margie Petersen Breast Center at Providence Saint John’s Health Center. She specializes in the treatment of patients with breast cancer and is involved in designing, implementing, and leading clinical trials to test new targeted therapies. She is board certified in internal medicine and medical oncology and received the Super Doctors Southern California 2022, 2023, and 2024 awards.
Dr. Parvin Peddi received her undergraduate degree from Vanderbilt University and her Doctor of Medicine degree from Duke University School of Medicine. She completed her internal medicine training at Washington University, where she also served as chief resident. She completed her fellowship in Hematology-Oncology at Washington University and at UCLA. Early in her career as faculty at UCLA, she received the Young Investigator Award from the American Society of Clinical Oncology for breast cancer research. She has also received many other awards and honors including Super Doctors® Southern California, Chief Editor of Washington Manual of Medical Therapeutics, and was selected as a Howard-Hughes Medical Institute Scholar to perform research at the National Institute of Health (NIH) in Bethesda, MD. Her research has been published in various medical journals, including the New England Journal of Medicine.
Dr. Peddi specializes in the treatment of breast cancer and strives to provide individualized, compassionate and cutting-edge care to each one of her patients. Supported by a multidisciplinary team of specialists, including medical and radiation oncologists, and surgeons, Dr. Peddi provides patients comfort, compassion, and reassurance of care excellence through vast clinical expertise and decades of cancer research.
Education & Training
Bachelor of Science Vanderbilt University, Nashville, TN
Doctor of Medicine Duke University School of Medicine, Durham, NC
Internal Medicine Residency Washington University School of Medicine
Chief Resident, Internal Medicine Washington University School of Medicine
Hematology-Oncology Fellowship Washington University School of Medicine University of California, Los Angeles
Honors and Awards
Super Doctors® Southern California (2022, 2023, 2024)
Young Investigator Award, American Society of Clinical Oncology
Chief Editor of Washington Manual of Medical Therapeutics, 33rd Edition
Mentors in Medicine Research Award, Washington University School of Medicine
Howard–Hughes Medical Institute/NIH Scholar, Duke University School of Medicine
Excellence in Research Award, Department of Biological Sciences, Vanderbilt University
Professional Memberships
American Society of Clinical Oncology
Testimonials
Breast Cancer Survivor, Michaela, shares her amazing story and how she felt about her treatment. Dr. Parvin Peddi, Director of Breast Medical Oncology at Saint John’s Cancer Institute, provides context for this special case.
“Dr. Parvin Peddi has the kindest eyes and warmth emanates from her the moment she enters a room. Because she is an oncologist, nobody wants to have to meet her in that setting, but she immediately made me feel like I was in the best hands and with someone who not only knows her stuff medically, but has an unparalleled bedside manner. She always asks if I have questions and really listens to me. And then asks again just to make sure she has covered everything. I do not ever wish cancer on any person but if you must be treated, you are one of the lucky ones if you get Parvin Peddi. She is my hero.” -Mindi
“It is my pleasure and honor to have the opportunity to give praise to Dr. Peddi. From the first day I met her, after being diagnosed with breast cancer, she brought calmness and hopefulness to me. She has a way of making you feel you are her only patient. If I was fearful or had a question, I could be guaranteed that within 24 hours I would hear from her. There is no doubt in my mind that her caring and treatments throughout my chemotherapy made it bearable. She is a true gift to all that need her.” – Maureen
“Dr. Parvin Peddi, MD has a glowing personality and is the true definition of the best of the best. Extremely down to earth and easy to talk to. She always has a smile on her face and makes every patient feel cared for, important and welcomed. In my experience, she’s the #1 oncologist because of her professional background and positive attributes where a patient like me is willing to travel any miles to stay under her medical supervision.” – Ching
Phase II randomized trial of a non-steroidal mouth wash for prevention and treatment of stomatitis in women with hormone receptor positive breast cancer treated with everolimus
Hormone receptor positive breast cancer: state of the art
Management of Breast Sarcoma
Ado-trastuzumab emtansine (T-DM1) in human epidermal growth factor receptor 2 (HER2)-positive metastatic breast cancer: latest evidence and clinical potential
Central nervous system toxicities of chemotherapeutic agents
PI3K pathway inhibitors for the treatment of brain metastases with a focus on HER2+ breast cancer
Fertility after breast cancer treatment
Nab-paclitaxel monotherapy in refractory pancreatic adenocarcinoma
A phase 1B study of dulanermin in combination with modified FOLFOX6 plus bevacizumab in patients with metastatic colorectal cancer
Noninfectious pneumonitis with the use of mTOR inhibitors in breast cancer
Vitamin D deficiency and prognostics among patients with pancreatic adenocarcinoma
Trastuzumab emtansine: the first targeted chemotherapy for treatment of breast cancer
BRAF V600E inhibition in anaplastic thyroid cancer
Successful resection after neoadjuvant therapy in pancreatic adenocarcinoma
Multi-institutional experience with FOLFIRINOX in pancreatic adenocarcinoma
Molecular basis of triple negative breast cancer and implications for therapy
